Updated July 2026. Scope: MoCRA (the Modernization of Cosmetics Regulation Act of 2022, which amended the U.S. Federal Food, Drug, and Cosmetic Act), the Responsible Person and the U.S. Agent roles. For the U.S. Agent role generally, see the guide on what a U.S. FDA Agent is and how to appoint one.
Key takeaways
- MoCRA created two different roles that are easy to confuse. The Responsible Person and the U.S. Agent are separate, held by separate parties, and cannot be collapsed into one.
- The Responsible Person is the manufacturer, packer, or distributor whose name appears on the product label. It owns cosmetic product listing, adverse event reporting, and safety substantiation.
- The U.S. Agent is the domestic communications contact for a foreign facility’s registration. It is an administrative and communication role, not an owner of product obligations.
- Facility registration and product listing are separate obligations, and neither is FDA approval of a facility or product.
The two roles MoCRA created
MoCRA brought cosmetic facilities and products under a registration and listing system. Two roles sit at the center of it, and foreign companies routinely mix them up:
- The Responsible Person, defined by reference to the label. It is the entity accountable for the product.
- The U.S. Agent, required for foreign facilities as part of facility registration. It is the domestic point of contact for FDA communications.
They answer different questions. The Responsible Person answers “who stands behind this product.” The U.S. Agent answers “who does FDA reach in the United States about this foreign facility.” A single company can need both filled, but not by the same designation, and often not by the same party.
The Responsible Person: who it is and what it owns
The Responsible Person is the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label, consistent with the FD&C Act (section 609(a)) and the Fair Packaging and Labeling Act (section 4(a)). It is tied to the label, not chosen freely.
| The Responsible Person owns | In practice |
|---|---|
| Cosmetic product listing | Submitting and maintaining the product listing with FDA |
| Adverse event reporting | Receiving, tracking, and reporting serious adverse events |
| Safety substantiation | Holding records that support the product’s safety |
| Labeling responsibilities | The label content that makes it the Responsible Person in the first place |
The Responsible Person carries the product-level accountability MoCRA assigns. That accountability does not move to a service provider by contract.
The U.S. Agent: who it is and what it does
Foreign facilities that manufacture or process cosmetics for the U.S. market must register, unless they qualify for MoCRA’s small-business exemption, which does not apply to certain product categories. A foreign facility that must register designates a U.S. Agent as part of that registration. The U.S. Agent is a domestic communications contact. Its function mirrors the U.S. Agent role across FDA-regulated products:
| The U.S. Agent does | In practice |
|---|---|
| Assist FDA communications with the foreign facility | A monitored domestic channel |
| Respond to questions about the facility’s imported products | Enough context to route correctly |
| Assist FDA in scheduling inspections | Coordinating between FDA and the foreign site |
| Receive FDA information or documents for the facility | A reliable delivery point |
The U.S. Agent role is administrative and communication only. Designating a U.S. Agent does not shift the facility’s or the Responsible Person’s obligations onto the agent.
Why they are not interchangeable
The two roles attach to different things. The Responsible Person attaches to the product and its label. The U.S. Agent attaches to a foreign facility’s registration. A distributor named on the label can be the Responsible Person for a product without being anyone’s U.S. Agent, and a U.S. Agent can be the communications contact for a facility without being the Responsible Person for any product made there.
For CENIT, the boundary is firm and worth stating plainly: CENIT acts as U.S. Agent and provides administrative submitter support. CENIT is not the Responsible Person for any client’s cosmetic products, does not own product listings, and does not assume adverse event reporting or safety substantiation. Those stay with the Responsible Person. Any provider that offers to be your Responsible Person is offering to take on product accountability that MoCRA ties to the label.
What registration and listing are not
Registering a facility and listing a product are notifications to FDA. Neither conveys FDA approval or endorsement of the facility or the product. A registration number or a listing number confirms the submission was made, nothing more.
They are also separate from each other and from the cosmetic-versus-drug question. A product that makes drug claims (for example, treating a skin condition, or providing SPF sun protection) is regulated differently and is outside cosmetic facility registration and listing. Where a product’s claims are ambiguous, the classification is a case-by-case question for review, not something a registration resolves.
Frequently asked questions
Is the U.S. Agent the same as the Responsible Person under MoCRA?
No. The U.S. Agent is the domestic communications contact for a foreign facility’s registration. The Responsible Person is the manufacturer, packer, or distributor whose name appears on the product label and who owns product listing, adverse event reporting, and safety substantiation. They are different roles.
Can one company be both the Responsible Person and the U.S. Agent?
The roles attach to different things (a product’s label versus a foreign facility’s registration), so they are filled separately. A single party could in principle hold both for a given arrangement, but the designations remain distinct and the obligations do not merge.
Does a foreign cosmetic facility need a U.S. Agent?
Yes. A foreign facility that must register under MoCRA designates a U.S. Agent as part of registration. The agent must be a real domestic communications contact.
Does registering a facility count as FDA approval?
No. Facility registration and product listing are notifications. Neither conveys FDA approval or endorsement of the facility or its products.
Who handles adverse event reporting?
The Responsible Person. Adverse event reporting, product listing, and safety substantiation sit with the Responsible Person, not with the U.S. Agent.
Related guides and services
- MoCRA Cosmetics U.S. FDA Agent services from CENIT Consulting: U.S. Agent designation and administrative submitter support for foreign cosmetic facilities. CENIT is your U.S. Agent, not your Responsible Person.
- For the U.S. Agent role across FDA-regulated products, see what a U.S. FDA Agent is and how to appoint one.
This article is for general information only and is not legal or regulatory advice. Teams remain responsible for regulatory decisions and staying current with applicable regulations and guidance.
Talk to CENIT Consulting about MoCRA U.S. Agent coverage for your foreign facility: book a 30-minute consult.